November 04, 2025

Get In Touch

Overminus Lens Therapy Improves Distance Exotropia Control In Young Children: JAMA

Overminus Lens Therapy Study

Overminus Lens Therapy and Distance Exotropia in Children

A recent study published in the journal JAMA Ophthalmology finds that overminus lens therapy improves control of distance exotropia in children but is associated with a greater myopic shift. Furthermore, the beneficial effect did not persist after discontinuation of the overminus treatment.

Overminus lens therapy is a nonsurgical treatment option for children with intermittent exotropia (IXT). In the therapy, an optical correction with more minus power than the cycloplegic refractive error is worn. Overminus lenses are used as a temporary treatment for improving IXT control in young children before considering surgery or orthoptics.

Some researchers found success in maintaining good control and binocular function after gradually reducing the strength of the overminus lenses over time and ultimately discontinuing the overminus lenses.

Angela M. Chen, from the Southern California College of Optometry at Marshall B. Ketchum University, Fullerton, and colleagues aimed to evaluate the effectiveness of overminus spectacles to improve distance IXT control.

For this purpose, the researchers performed a randomized clinical trial at 56 clinical sites between January 2017 and January 2019. The study enrolled 386 children aged 3 to 10 years with IXT, a mean distance control score of 2 or worse, and a refractive error between 1.00 and −6.00 diopters (D).

196 participants received overminus spectacle therapy (−2.50 D for 12 months, then −1.25 D for 3 months, followed by nonoverminus spectacles for 3 months) and 190 received nonoverminus spectacle use.

Key Findings of the Study

  • Mean distance control at 12 months was better in participants treated with overminus spectacles than with nonoverminus spectacles (1.8 vs 2.8 points).
  • At 18 months, there was little or no difference in mean distance control between overminus and nonoverminus groups (2.4 vs 2.7 points).
  • Myopic shift from baseline to 12 months was greater in the overminus than the nonoverminus group (−0.42 D vs −0.04 D), with 33 of 189 children (17%) in the overminus group vs 2 of 169 (1%) in the nonoverminus group having a shift higher than 1.00 D.

"When assessed wearing overminus spectacles after 12 months of overminus treatment, children 3 to 10 years of age had improved distance exotropia control. However, the treatment was associated with increased myopic shift," wrote the authors.

"The beneficial effect of overminus lens therapy on distance exotropia control was not maintained after treatment was tapered off for 3 months and children were examined 3 months later."

The study titled, "Overminus Lens Therapy for Children 3 to 10 Years of Age With Intermittent Exotropia: A Randomized Clinical Trial," is published in the journal JAMA Ophthalmology.

DOI: https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2777181

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!